Oct 19, 2021 / 12:00PM GMT
Presentation
Oct 19, 2021 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Mike Cola
Avalo Therapeutics, Inc. - CEO & Chairman of the Board
* Schond Greenway
Avalo Therapeutics, Inc. - CFO
* Jeff Wilkins
Avalo Therapeutics, Inc. - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Chris Howerton
Jefferies Group (Trades, Portfolio) LLC - Analyst
=====================
Chris Howerton - Jefferies Group (Trades,
Avalo Therapeutics Inc
(NAS:AVTX)
$
19.77
+1.42 (+7.74%)
Market Cap: 1.06 Bil
Enterprise Value: 660.23 Mil
PE Ratio: 0
PB Ratio: 1.92
GF Score: 24/100 Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation Transcript
Oct 19, 2021 / 12:00PM GMT
Release Date Price:
$6451.2
(+1.36%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot